JCJuliana Geremias Chichorro

Juliana Geremias Chichorro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Juliana Geremias Chichorro has a total of 165 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ultrasonic Vocalizations in the Context of Rodent Chronic Pain Research: A Protocol

    by de Souza, Camila Pasquini, Vanessa B. P. Lejeune, Roberto Andreatini, Rainer K. W. Schwarting, Juliana Geremias Chichorro

  • Emerging Pharmacological Strategies for Trigeminal Neuralgia

    by Juliana Geremias Chichorro, Victor Augusto Benedicto dos Santos, Gerald W. Zamponi

    Trigeminal neuralgia can be a debilitating pain condition that affects women more frequently than men and for which there are only limited therapeutic avenues. Trigeminal neuralgia can either be idiopathic (where there is no clearly identifiable cause), classical (which typically involves neurovascular compression of the trigeminal root entry zone) or secondary which results from nerve damage due to other causes. First-line treatments for trigeminal neuralgia include the sodium channel blockers carbamazepine and oxcarbazepine, whose mechanism of action is to stabilize the inactivated state of sodium channels, thereby reducing the electrical activities of trigeminal neurons. Second-line treatments include gabapentinoids, which act on Cavα2δ subunits of high voltage activated calcium channels to inhibit synaptic transmission in the trigeminal pain pathway. Both of these treatment avenues exhibit a number of adverse effects and many patients are refractory. Hence, new avenues for combatting trigeminal neuralgia are needed. In this review article, we discuss clinical evidence for efficacy and benefits of novel pharmacological treatment approaches for trigeminal neuralgia, including the inhibition of CGRP receptors, activation and desensitization of TRPV1 channels, the development of new generations of sodium channel blockers, and the use of botulinum toxin. We conclude that while there are potential benefits of these approaches, larger well-controlled cohort studies are needed to provide a definitive answer.


  • Open Access

    Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner

    by Gabriel Camargo de Oliveira, Darciane Favero Baggio, Vanessa Bordenowsky Pereira Lejeune, Laura Storithont Quinelato, Fernanda Mariano Ribeiro da Luz, Aleksander Roberto Zampronio, Luana Fischer, Juliana Geremias Chichorro

    Objective: This study explores whether sleep restriction (SR) and caffeine intake affect migraine susceptibility by testing if each condition, alone or in combination, precipitates migraine‐like responses to subthreshold doses of calcitonin gene‐related peptide (CGRP) or pituitary adenylate cyclase‐activating polypeptide (PACAP) in male and female rats. Background: Migraine is a debilitating neurological syndrome that affects approximately 15% of the global population, with a three‐fold higher prevalence in females compared to males. Among the peripheral mechanisms underlying migraine, the release of vasoactive peptides by trigeminal ganglion (TG) neurons, such as CGRP and PACAP, plays a crucial role. Various environmental triggers—including sleep or food deprivation, caffeine intake or withdrawal, stress, and light exposure—have been associated with the onset of migraine attacks; however, the mechanisms by which these factors modulate nociceptive sensitization remain poorly understood. Methods: Male and female Wistar rats were subjected to SR for 6 h daily over 3 consecutive days using the gentle handling method, and the periorbital mechanical allodynia was assessed using von Frey filaments before and after each day of SR. Next, a subthreshold dose of CGRP (38 ng/10 μL) or PACAP (0.1 ng/10 μL) was administered into the TG on the third day of SR to evaluate whether sleep loss enhances susceptibility to migraine‐like responses. Finally, two additional experiments were conducted to investigate the influence of caffeine (50 mg/kg, orally) exposure in combination of SR in CGRP and PACAP effects. In all experiments, on day 4 (i.e., 24 h after the last SR), the animals were exposed for 1 h to an aversive light for verification of latent sensitization. Results: The results demonstrated that SR alone did not alter the periorbital mechanical threshold in either male or female rats. However, when SR was combined with the administration of CGRP or PACAP at subthreshold doses, a significant periorbital mechanical allodynia developed in female, but not in male rats. The exposure to light in the subsequent day caused a transitory reactivation of mechanical allodynia only in females. In well‐rested animals, a 3‐day caffeine regimen enabled behaviorally subthreshold doses of CGRP or PACAP to elicit migraine‐like responses in females, but not in males. In sleep‐restricted animals, combining caffeine with subthreshold doses of CGRP or PACAP rendered males susceptible to migraine‐like responses and markedly exacerbated these responses in females, including 1 day later, after light exposure. Conclusion: These findings suggest that SR facilitates trigeminovascular sensitization, promoting migraine‐like responses in a sex‐specific manner and highlighting caffeine as an enhancer of this interaction. Beyond reinforcing the association between poor sleep and migraine, the data offer new insights into the involvement of the purinergic system and sex differences in migraine pathophysiology. image


  • Open Access

    Antinociceptive and anti-inflammatory effects of a formulation based on Alpinia zerumbet essential oil: an in vivo and in vitro approach

    by Wagner Hummig, Julia Maria Zortea, Victor Augusto Benedicto dos Santos, Luiz Eduardo Nunes Ferreira, Juliana Geremias Chichorro

    Background: Current pharmacological treatments for acute orofacial pain present limitations, risks, and side effects. Thus, the search for safer alternatives is justified. The essential oil of Alpinia zerumbet (EOAz) has been used in the treatment of several medical conditions, including pain and inflammation, but scientific validation is scarce. The aim of this study was to investigate the antinociceptive and anti-inflammatory effects of EOAz in models of acute orofacial pain in rats and in inflammatory parameters in vitro. Methods: Adult male Wistar rats were subjected to intraoral incision surgery, a model of postoperative pain. The effect of the facial topical application (1 to 3 times a day for 3 days) of EOAz or a formulation based on EOAz (Fb-EOAz) was assessed on heat and mechanical hyperalgesia. The same rats were tested in the open field test (OFT) to assess the influence of the treatments on rats’ locomotion. Moreover, the effects of the treatments were evaluated on facial heat hyperalgesia induced by lipopolysaccharide (LPS), a model of myofascial pain, and in vitro, in the release of nitric oxide (NO) and interleukin-6 in macrophages stimulated by LPS. Results: EOAz and Fb-EOAz reduced postoperative heat hyperalgesia, but only Fb-EOAz reduced postoperative mechanical hyperalgesia and heat hyperalgesia induced by LPS. Fb-EOAz reduced NO and interleukin-6 release by macrophages stimulated by LPS. None of the treatments affected the rat’s locomotion. Conclusions: These data provide preclinical evidence of antinociceptive and anti-inflammatory effects of Fb-EOAz. This approach may represent an alternative or adjuvant therapy in the control of inflammatory and myofascial orofacial pain.


  • Open Access

    Efficacy of different cannabinoid compounds on migraine-like responses in female rats

    by Fernanda Mariano Ribeiro da Luz, Alexandre Ottoni Kaup, Darciane Favero Baggio, Flavio Henrique de Rezende Costa, Juliana Geremias Chichorro

    Aim: To investigate the effect of different cannabinoid compounds on the periorbital mechanical allodynia and photosensitivity in acute and chronic migraine models. Methods: Female Wistar rats were treated systemically with different cannabinoid compounds (cannabidiol, CBD, 30 mg/kg; CBD and cannabigerol, CBD/CBG – 2:1; CBD and 0.3% tetrahydrocannabinol (CBD/THC); or CBD/CBG/THC) followed by injection of calcitonin-gene-related peptide (CGRP) or pituitary adenylate cyclase-activating polypeptide (PACAP) into the trigeminal ganglion to induced immediate periorbital mechanical allodynia and late photosensitivity. The effect of CBD and CBD/THC was also assessed on periorbital mechanical allodynia and photosensitivity in the chronic migraine model induced by repeated nitroglycerin (NTG) injections. Results: Periorbital mechanical allodynia induced by CGRP was significantly reduced by CBD alone and combined with THC or CBG. CBD/THC was the most effective treatment in this condition since it presented the longer effect (up to three hours) and was the only treatment capable of reducing late photosensitivity associated with CGRP. All four compounds presented antinociceptive effect on acute migraine-like responses induced by PACAP, with CBD alone presenting the longer effect (from 30 minutes up to two hours). Except for CBD/CBG, all compounds also reduced (up to two hours) late photosensitivity associated with PACAP. In the chronic migraine model induced by NTG, CBD reduced periorbital mechanical allodynia on days 5, 7 and 11, while CBD/THC suppressed the development of periorbital allodynia up to day 13 and significantly reduced photosensitivity up to three hours. Conclusion: Altogether, these results suggest that cannabinoid compounds may represent effective alternatives for the treatment of episodic and chronic migraine.


  • Dipyrone induces sex-dependent latent sensitization in a preclinical model of medication overuse headache

    by Fernanddo José Spagnol, Julia Maria Zortea, Larissa Cieslinsky Gomes, Fernanda Mariano Ribeiro da Luz, Darciane Favero Baggio, Vanessa Bordenowsky Pereira Lejeune, Luiz Eduardo Nunes Ferreira, Caroline Machado Kopruszinski, Juliana Geremias Chichorro


  • Characterization of behavioral and emotional responses of male and female juvenile rats in the orofacial formalin test following acetaminophen treatment

    by Yasmin Neiva Tomaz Saurin, Renata Cristiane dos Reis, Darciane Favero Baggio, Rainer K.W. Schwarting, Roberto Andreatini, Victor Augusto Benedicto dos Santos, Juliana Geremias Chichorro


  • Open Access

    CaV3.2 T-type calcium channels contribute to CGRP- induced allodynia in a rodent model of experimental migraine

    by Darciane F. Baggio, Eder Gambeta, Ivana A. Souza, Sun Huang, Gerald W. Zamponi, Juliana G. Chichorro

    Migraine is a painful neurological syndrome characterized by attacks of throbbing headache, of moderate to severe intensity, which is associated with photo- and phono- sensitivity as well as nausea and vomiting. It affects about 15% of the world’s population being 2–3 times more prevalent in females. The calcitonin gene-related peptide (CGRP) is a key mediator in the pathophysiology of migraine, and a significant advance in the field has been the development of anti-CGRP therapies. The trigeminal ganglion (TG) is thought to be an important site of action for these drugs. Moreover, experimental migraine can be induced by CGRP injection in the TG. The signaling pathway induced by CGRP in the TG is not fully understood, but studies suggest that voltage-gated calcium channels contribute to CGRP effects relevant to migraine. We hypothesised that CGRP injection in the TG enhances CaV3.2 T-type calcium channel currents to contribute to the development of periorbital mechanical allodynia. A Co-Immunoprecipitation assay in tsA-201 cells revealed that CaV3.2 channels form a complex with RAMP-1, a component of the CGRP receptor. Constitutive CGRPR activity was able to inhibit CaV3.2 channels and induce a depolarizing shift in both activation and inactivation curves. Incubation of TG neurons with CGRP increased T-type current density by ~ 3.6 fold, an effect that was not observed in TG neurons from CaV3.2 knockout mice. Incubation of TG neurons with Z944, a pan T-type channel blocker, resulted in an approximately 80% inhibition of T-type currents. In vivo, this treatment abolished the development of periorbital mechanical allodynia induced by CGRP in male and female mice. Likewise, CaV3.2 knockout mice did not develop periorbital mechanical allodynia after intraganglionic CGRP injection. Finally, we demonstrated that the CGRP effect depends on the activation of its canonical GPCR, followed by protein kinase A activation. The present study suggests that CGRP modulates CaV3.2 in the TG, an effect possibly mediated by the canonical CGRP receptor and PKA activation. The increase in T-type currents in the TG may represent a contributing factor for the initiation and maintenance of the headache pain during migraine.


  • Open Access

    Effect of peppermint essential oil (Mentha piperita L.) in migraine-like responses in female rats

    by Laura de Oliveira Koren, Vanessa Bordenowsky Pereira Lejeune, Darciane Favero Baggio, Fernanda Mariano Ribeiro da Luz, Juliana Geremias Chichorro

    Migraine is a severe and disabling neurological disorder characterized by headache, photophobia, phonophobia, nausea and vomiting. It is considered the top cause of years lived with disability between the ages of 15–49, being two to three times more common in women than in men. Pharmacological treatment of migraine has advanced in the past years but is still considered unsatisfactory for a significant number of patients. There is growing evidence that essential oils may provide benefit for migraineurs. Herein it was tested the hypothesis that peppermint essential oil (Mentha piperita L.) could reduce migraine-related responses in rats. The model consisted in the injection of calcitonin-gene-related peptide (CGRP) in the trigeminal ganglion (TG) of female rats to induce the development of immediate periorbital cutaneous allodynia and late photosensitivity (24 h after CGRP). Inhalation of the peppermint essential oil during 15 minutes before CGRP injection in the TG did not reduce periorbital allodynia and photosensitivity of female rats. However, when the exposure occurred after CGRP injection, peppermint essential oil caused a significant reduction in both parameters. Likewise, intranasal application of menthol, a major component of peppermint essential oil caused a significant reduction of periorbital allodynia induced by CGRP. In conclusion, peppermint essential oil and menthol may represent a safe, low cost and noninvasive adjuvant abortive therapy for headache pain in migraine patients. However, further high-quality clinical studies are clearly warranted to determine efficacy, safety and to establish their best treatment regimen.

  • Comparative study of the effects of ibuprofen, acetaminophen, and codeine in a model of orofacial postoperative pain in male and female rats

    by Julia Maria Zortea, Darciane Favero Baggio, Fernanda Mariano Ribeiro da Luz, Vannessa Bordenowsky Pereira Lejeune, Fernanddo José Spagnol, Juliana Geremias Chichorro

    Pain management is a primary goal after oral surgeries, but little is known about sex differences in the sensitivity to analgesics. This study aimed to compare the efficacy of three drugs with analgesic potential on heat and mechanical hyperalgesia, spontaneous pain and locomotion on male and female rats subjected to a model of orofacial postoperative pain. Male and female Wistar rats were submitted to intraoral incision or sham surgery, and on postoperative day 3, the effect of the ibuprofen (30 and 100 mg/kg), acetaminophen (100 and 300 mg/kg) and codeine (3 and 10 mg/kg) was assessed on responses to heat and mechanical facial stimulation, facial grooming, and locomotion. Ibuprofen reduced heat and mechanical hyperalgesia and grooming behavior in male and female rats in a non-sedative dose; acetaminophen dose-dependently reduced the mechanical hyperalgesia and abolished the heat hyperalgesia and the grooming behavior but caused sedation in both sexes; codeine dose-dependently reduced the mechanical hyperalgesia in male and female rats, and reduced the heat hyperalgesia, but females were less sensitive than males. It reduced spontaneous facial grooming in both sexes, but induced hyperlocomotion in females. Ibuprofen presented the most favorable profile, since it reduced over 50% heat and mechanical hyperalgesia in male and female rats, and significantly reduced spontaneous pain, without causing sedation or affecting locomotion. The identification of sex differences in the sensitivity and safety profile of frequently used analgesics can help guide the choice of more effective individualized therapies for pain control.